Radiographic Progression According to Baseline C-Reactive Protein Levels and Other Risk Factors in Psoriatic Arthritis Patients Treated With Tofacitinib or Adalimumab

Journal of Rheumatology - Canada
doi 10.3899/jrheum.180971
Full Text
Abstract

Available in full text

Date
Authors
Publisher

The Journal of Rheumatology

Related search

Radiographic Progression of Structural Joint Damage in Patients With Active Psoriatic Arthritis Treated With Ixekizumab Over 52 Weeks

SKIN The Journal of Cutaneous Medicine
2017English

Risk Factors for Radiographic Progression in Psoriatic Arthritis: Subanalysis of the Randomized Controlled Trial ADEPT

Arthritis Research and Therapy
RheumatologyAllergyImmunology
2010English

Incidence and Prevalence of Cardiovascular Risk Factors Among Patients With Rheumatoid Arthritis, Psoriasis, or Psoriatic Arthritis

Arthritis Care and Research
Rheumatology
2017English

Elevated Liver Enzyme Tests Among Patients With Rheumatoid Arthritis or Psoriatic Arthritis Treated With Methotrexate and/or Leflunomide

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
2009English

Cardiovascular Risk in Patients With Psoriatic Arthritis

Terapevticheskii Arkhiv
Internal MedicineEndocrinologyMetabolismDiabetes
2016English

Elevated C-Reactive Protein (CRP) Levels in Patients With Recurrent Urticaria and/or Angioedema

The Internet Journal of Asthma, Allergy and Immunology
2002English

Adalimumab Improves Joint-Related and Skin-Related Functional Impairment in Patients With Psoriatic Arthritis: Patient-Reported Outcomes of the Adalimumab Effectiveness in Psoriatic Arthritis Trial

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
2006English

C-Reactive Protein Levels in Patients at Cardiovascular Risk: EURIKA Study

BMC Cardiovascular Disorders
Cardiovascular MedicineCardiology
2014English

THU0203 Changes in C-Reactive Protein and Lipid Levels in Patients With Rheumatoid Arthritis Treated With Abt-494, a Selective Jak-1 Inhibitor

2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy